Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Clinical significance of circulating tumor cells in gastric cancer patients.

Zhou J, Ma X, Bi F, Liu M.

Oncotarget. 2017 Apr 11;8(15):25713-25720. doi: 10.18632/oncotarget.14879. Review.

2.

Circulating tumor cells expressing cancer stem cell marker CD44 as a diagnostic biomarker in patients with gastric cancer.

Watanabe T, Okumura T, Hirano K, Yamaguchi T, Sekine S, Nagata T, Tsukada K.

Oncol Lett. 2017 Jan;13(1):281-288. doi: 10.3892/ol.2016.5432. Epub 2016 Nov 24.

3.

Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.

Yu XM, Wu YC, Liu X, Huang XC, Hou XX, Wang JL, Cheng XL, Mao WM, Ling ZQ.

Int J Mol Sci. 2016 Nov 5;17(11). pii: E1845.

4.

Short term ex-vivo expansion of circulating head and neck tumour cells.

Kulasinghe A, Perry C, Warkiani ME, Blick T, Davies A, O'Byrne K, Thompson EW, Nelson CC, Vela I, Punyadeera C.

Oncotarget. 2016 Sep 13;7(37):60101-60109. doi: 10.18632/oncotarget.11159.

5.

Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics.

Chen W, Allen SG, Reka AK, Qian W, Han S, Zhao J, Bao L, Keshamouni VG, Merajver SD, Fu J.

BMC Cancer. 2016 Aug 8;16:614. doi: 10.1186/s12885-016-2638-x.

6.

Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection.

Murlidhar V, Ramnath N, Nagrath S, Reddy RM.

Cancers (Basel). 2016 Jun 28;8(7). pii: E61. doi: 10.3390/cancers8070061. Review.

7.

The number of tumorspheres cultured from peripheral blood is a predictor for presence of metastasis in patients with breast cancer.

Pizon M, Schott D, Pachmann U, Pachmann K.

Oncotarget. 2016 Jul 26;7(30):48143-48154. doi: 10.18632/oncotarget.10174.

8.

The Role of Surface Receptor Density in Surface-Initiated Polymerizations for Cancer Cell Isolation.

Lilly JL, Berron BJ.

Langmuir. 2016 Jun 7;32(22):5681-9. doi: 10.1021/acs.langmuir.6b01146. Epub 2016 May 26.

PMID:
27206735
9.

Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients.

Hensler M, Vančurová I, Becht E, Palata O, Strnad P, Tesařová P, Čabiňaková M, Švec D, Kubista M, Bartůňková J, Špíšek R, Sojka L.

Oncoimmunology. 2015 Dec 10;5(4):e1102827. eCollection 2016 Apr.

10.

Detection of circulating tumor cells by p75NTR expression in patients with esophageal cancer.

Yamaguchi T, Okumura T, Hirano K, Watanabe T, Nagata T, Shimada Y, Tsukada K.

World J Surg Oncol. 2016 Feb 20;14(1):40. doi: 10.1186/s12957-016-0793-9.

11.

Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress.

Hardingham JE, Grover P, Winter M, Hewett PJ, Price TJ, Thierry B.

Mol Med. 2015 Oct 27;21 Suppl 1:S25-31. doi: 10.2119/molmed.2015.00149. Review.

12.

The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer.

Huang WL, Wei F, Wong DT, Lin CC, Su WC.

Biomed Res Int. 2015;2015:340732. doi: 10.1155/2015/340732. Epub 2015 Sep 13. Review.

13.

Current Understanding of Circulating Tumor Cells - Potential Value in Malignancies of the Central Nervous System.

Adamczyk LA, Williams H, Frankow A, Ellis HP, Haynes HR, Perks C, Holly JM, Kurian KM.

Front Neurol. 2015 Aug 10;6:174. doi: 10.3389/fneur.2015.00174. eCollection 2015. Review.

14.

A Quantitative Perspective on Surface Marker Selection for the Isolation of Functional Tumor Cells.

Cahall CF, Lilly JL, Hirschowitz EA, Berron BJ.

Breast Cancer (Auckl). 2015 Jul 27;9(Suppl 1):1-11. doi: 10.4137/BCBCR.S25461. eCollection 2015. Review.

15.

Prognostic Value of Circulating Tumor Cells in Ovarian Cancer: A Meta-Analysis.

Zhou Y, Bian B, Yuan X, Xie G, Ma Y, Shen L.

PLoS One. 2015 Jun 22;10(6):e0130873. doi: 10.1371/journal.pone.0130873. eCollection 2015.

16.

Circulating tumor cells in oral squamous cell carcinoma-an enigma or reality?

Anitha N, Jimson S, Masthan KM, Jacobina JJ.

J Pharm Bioallied Sci. 2015 Apr;7(Suppl 1):S173-5. doi: 10.4103/0975-7406.155893. Review.

17.

Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.

Chen JF, Ho H, Lichterman J, Lu YT, Zhang Y, Garcia MA, Chen SF, Liang AJ, Hodara E, Zhau HE, Hou S, Ahmed RS, Luthringer DJ, Huang J, Li KC, Chung LW, Ke Z, Tseng HR, Posadas EM.

Cancer. 2015 Sep 15;121(18):3240-51. doi: 10.1002/cncr.29455. Epub 2015 May 14.

18.

Breast cancer intra-tumor heterogeneity.

Martelotto LG, Ng CK, Piscuoglio S, Weigelt B, Reis-Filho JS.

Breast Cancer Res. 2014 May 20;16(3):210. doi: 10.1186/bcr3658. Review.

19.

Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue.

Lyberopoulou A, Aravantinos G, Efstathopoulos EP, Nikiteas N, Bouziotis P, Isaakidou A, Papalois A, Marinos E, Gazouli M.

PLoS One. 2015 Apr 22;10(4):e0123902. doi: 10.1371/journal.pone.0123902. eCollection 2015.

20.

Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin.

Vikeså J, Møller AK, Kaczkowski B, Borup R, Winther O, Henao R, Krogh A, Perell K, Jensen F, Daugaard G, Nielsen FC.

BMC Cancer. 2015 Mar 19;15:151. doi: 10.1186/s12885-015-1128-x.

Supplemental Content

Support Center